U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661030) titled 'The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time' on Sept. 14, 2025.
Brief Summary: To confirm that initiating Dotinurad for uric acid uric acid lowering during the acute phase of gout is non-inferior to initiating it after the acute phase of gout has subsided, and to analyze whether initiating Dotinurad treatment during the acute phase will increase the pain level, the recurrence rate of gout, and the inflammatory level of patients.
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition:
Gout
Intervention:
DRUG: Dotinurad
The drug used in the treatment ...